Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nirosen Vijiaratnam

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Brain : a Journal of Neurology|August 3, 2023
How should we be using biomarkers in trials of disease modification in Parkinson's disease?Nirosen Vijiaratnam, Thomas Foltynie
Neuropharmacology|October 17, 2021
Disease modifying therapies III: Novel targetsNirosen Vijiaratnam, Thomas Foltynie
Drugs|May 9, 2020
Therapeutic Strategies to Treat or Prevent Off Episodes in Adults with Parkinson's DiseaseNirosen Vijiaratnam, Thomas Foltynie
Neurology India|January 12, 2018
Botulinum toxin in patients with Meige's syndromeNirosen Vijiaratnam, Tissa Wijeratne
Movement Disorders Clinical Practice|March 7, 2019
How Do I Manage Patients With the Levodopa/Carbidopa Intestinal Gel?Nirosen Vijiaratnam, Carolyn M Sue
Internal Medicine Journal|April 7, 2018
Levodopa-carbidopa intestinal gel: 'dismantling the road blocks of a journey'Nirosen Vijiaratnam, Carolyn M Sue
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 18, 2017
Treatment advances in Parkinson disease: Same script different cast?Nirosen Vijiaratnam, Andrew H Evans
Muscle & Nerve|March 2, 2016
Reply: Pharyngeal-cervical-brachial/Miller-Fisher overlap: A possible central variantKai-Zheong Lim, Nirosen Vijiaratnam
Muscle & Nerve|June 3, 2015
Pharyngeal-cervical-brachial/Miller-Fisher overlap: A possible central variantKai-Zheong Lim, Nirosen Vijiaratnam
International Journal of MS Care|December 23, 2017
Alemtuzumab in Multiple Sclerosis: Lessons from Social Media in Enhancing Patient CareLouise Rath, Nirosen Vijiaratnam, Olga Skibina
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Brain : a Journal of Neurology|August 3, 2023
How should we be using biomarkers in trials of disease modification in Parkinson's disease?Nirosen Vijiaratnam, Thomas Foltynie
Neuropharmacology|October 17, 2021
Disease modifying therapies III: Novel targetsNirosen Vijiaratnam, Thomas Foltynie
Drugs|May 9, 2020
Therapeutic Strategies to Treat or Prevent Off Episodes in Adults with Parkinson's DiseaseNirosen Vijiaratnam, Thomas Foltynie
Neurology India|January 12, 2018
Botulinum toxin in patients with Meige's syndromeNirosen Vijiaratnam, Tissa Wijeratne
Movement Disorders Clinical Practice|March 7, 2019
How Do I Manage Patients With the Levodopa/Carbidopa Intestinal Gel?Nirosen Vijiaratnam, Carolyn M Sue
Internal Medicine Journal|April 7, 2018
Levodopa-carbidopa intestinal gel: 'dismantling the road blocks of a journey'Nirosen Vijiaratnam, Carolyn M Sue
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 18, 2017
Treatment advances in Parkinson disease: Same script different cast?Nirosen Vijiaratnam, Andrew H Evans
Muscle & Nerve|March 2, 2016
Reply: Pharyngeal-cervical-brachial/Miller-Fisher overlap: A possible central variantKai-Zheong Lim, Nirosen Vijiaratnam
Muscle & Nerve|June 3, 2015
Pharyngeal-cervical-brachial/Miller-Fisher overlap: A possible central variantKai-Zheong Lim, Nirosen Vijiaratnam
International Journal of MS Care|December 23, 2017
Alemtuzumab in Multiple Sclerosis: Lessons from Social Media in Enhancing Patient CareLouise Rath, Nirosen Vijiaratnam, Olga Skibina
Pageof 7